BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17

• Press Releases

  NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors

  February 10, 2026

   · 

  2 min read
• Press Releases

  Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

  February 10, 2026

   · 

  5 min read
• Press Releases

  Evecxia Doses First Patient in Phase 1b Brain Target Engagement Study of Serotonin Synthesis Amplification Therapy

  February 10, 2026

   · 

  2 min read
• Press Releases

  NYU Langone Perlmutter Cancer Center Names Leading Clinician-Researcher as New Chair of Radiation Oncology

  February 10, 2026

   · 

  3 min read
• Press Releases

  Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India

  February 10, 2026

   · 

  3 min read
• Press Releases

  Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies

  February 10, 2026

   · 

  2 min read
• Press Releases

  Galux Raises $29M Series B to Advance AI-Driven Protein Design for Drug Discovery

  February 10, 2026

   · 

  3 min read
• Press Releases

  TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors

  February 10, 2026

   · 

  7 min read
• Press Releases

  SCIEX announces Echo® MS+ system integration with ZenoTOF 8600 system, delivering enhanced sensitivity for high-throughput screening

  February 10, 2026

   · 

  3 min read
• Press Releases

  AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors

  February 10, 2026

   · 

  4 min read